Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.22 USD | +2.28% | -0.70% | +17.93% |
05-02 | Wedbush Raises SpringWorks Therapeutics' Price Target to $75 From $70, Keeps Outperform Rating | MT |
05-02 | SpringWorks Therapeutics Shares Fall After Wider-Than-Expected Q1 Loss | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.93% | 3.13B | |
+2.50% | 108B | |
+9.56% | 105B | |
+1.57% | 23.46B | |
-11.81% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.76% | 17.19B | |
+5.95% | 13.99B | |
+34.72% | 12.53B |
- Stock Market
- Equities
- SWTX Stock
- News SpringWorks Therapeutics, Inc.
- Transcript : SpringWorks Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 07